TNS4 and neoplasm: CTEN knockdown resulted in significantly reduced tumour growth (p < 0.05 at 5 weeks; Figure 2b–d), without any subjective difference in tumour morphology, and a reduction in micrometastases (six (shCtrl) vs. three (shCTEN); Figure 2b,e).